Molecular Biomedicine : Impact Factor & More
eISSN: 2662-8651
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Molecular Biomedicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Springer |
| Language | English |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sichuan International Medical Exchange & Promotion Association |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 10 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Molecular Biomedicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Biomedicine
Correction: UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family.
- 27 Apr 2026
- Molecular biomedicine
Subarachnoid hemorrhage: epidemiology, risk factors, pathogenesis, and clinical therapies.
- 27 Apr 2026
- Molecular biomedicine
Development and characterization of 3D spinal cord organoids to advance the study of amyotrophic lateral sclerosis.
- 24 Apr 2026
- Molecular biomedicine
PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cells.
- 23 Apr 2026
- Molecular biomedicine
DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospects.
- 22 Apr 2026
- Molecular biomedicine
In vivo CAR-cell therapy: current challenges and emerging therapeutic advances.
- 20 Apr 2026
- Molecular biomedicine
Correction: UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family.
- 27 Apr 2026
- Molecular biomedicine
Subarachnoid hemorrhage: epidemiology, risk factors, pathogenesis, and clinical therapies.
- 27 Apr 2026
- Molecular biomedicine
Development and characterization of 3D spinal cord organoids to advance the study of amyotrophic lateral sclerosis.
- 24 Apr 2026
- Molecular biomedicine
PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cells.
- 23 Apr 2026
- Molecular biomedicine
DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospects.
- 22 Apr 2026
- Molecular biomedicine
In vivo CAR-cell therapy: current challenges and emerging therapeutic advances.
- 20 Apr 2026
- Molecular biomedicine
FAQs on Molecular Biomedicine
How many articles did Molecular Biomedicine publish last year? 
Who is the publisher of Molecular Biomedicine?
